Plain-English translation of NCT05786547 on ClinicalTrials.gov โ ยท Source last updated ยท Translation generated ยท How we translate trials
Phase 3 โ Testing in thousands of people, comparing the treatment against what doctors currently use. This is the last big step before approval.
This trial is testing whether โ a medication proven to help people quit smoking โ works well for people living with HIV when combined with a personalized mobile phone program called Positively Smoke Free-Mobile. The study will compare this combination approach to standard care (brief advice and a referral to a quit-smoking hotline) to see which helps more people successfully quit tobacco.
People living with HIV smoke at much higher rates than the general population, which increases serious health risks on top of their existing condition. This medication has worked well in other groups, but researchers want to know if it's effective and safe specifically for people with HIV in India who are ready to quit.
You likely qualify ifโฆ
You likely don't qualify ifโฆ
If you join this study, you will either receive (the medication) plus access to the Positively Smoke Free-Mobile program on your phone for 42 days of personalized quit-smoking support, or you will receive standard care with brief advice and a referral to a quit-smoking hotline. You will attend clinic visits, complete surveys, and participate for about 24 weeks (roughly 6 months). The medication involves a gradual dose increase over the first week, then continues for 12 weeks total.
AI-generated summary from trial data ยท Jun 9, 2026 ยท Not medical advice
United States
India